NCT07536646

Brief Summary

Lipedema is a chronic disorder characterized by abnormal bilateral fat deposition in the extremities, predominantly affecting women and typically beginning at puberty. The trunk, hands, and feet are usually spared. Despite its relatively high prevalence, lipedema is frequently underrecognized in clinical practice and is often confused with conditions such as obesity, venous insufficiency, and lymphedema. Patients commonly present with pain, tenderness, and easy bruising. Current imaging methods have demonstrated increased subcutaneous tissue thickness and fluid infiltration in lipedema; however, no imaging modality has yet been established as a definitive diagnostic tool. Shear wave elastography (SWE) is a noninvasive ultrasound-based technique that enables quantitative assessment of tissue stiffness and may provide additional information regarding tissue structure and mechanical properties. In this study, we aim to compare lower extremity subcutaneous tissue stiffness in patients with lipedema and healthy controls using SWE. As a secondary objective, we aim to evaluate abdominal subcutaneous tissue stiffness in patients with lipedema and compare these findings with both lower extremity measurements in the same patients and abdominal measurements in individuals without lipedema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 11, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 11, 2026

Last Update Submit

April 11, 2026

Conditions

Keywords

shearwave elastographylipedematissue elasticity

Outcome Measures

Primary Outcomes (1)

  • Tissue elasticity, as measured by shear-wave elastography (SWE)

    Comparison of tissue elasticity at the specified sites in both legs between patients with lipedema and healthy controls

    1 day

Secondary Outcomes (1)

  • Tissue elasticity, as measured by shear-wave elastography (SWE)

    1 day

Study Arms (2)

lipedema group

Women aged ≥18 years with lipedema (stages 1-3)

Diagnostic Test: Shearwave elastography

control group

healty controls

Diagnostic Test: Shearwave elastography

Interventions

Shearwave elastographyDIAGNOSTIC_TEST

Tissue elasticity was assessed using shear wave elastography (SWE) by a radiologist with 18 years of experience, using an RS 85 US device (Samsung Medison, Seoul, Korea) with an SL 10-2 linear probe. Patients were examined in the supine position, and a 10-mm layer of high-viscosity gel was applied to minimize compression. Bilateral measurements were obtained from four sites (anterior thigh, pretibial region, lateral leg, and abdomen), with three measurements per site averaged for analysis.

control grouplipedema group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen aged ≥18 years with lipedema (stages 1-3) and healthy controls were included.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women aged ≥18 years with lipedema (stages 1-3) and healthy controls were included.

You may qualify if:

  • Women aged ≥18 years with lipedema (stages 1-3) and healthy controls with adequate cognitive function

You may not qualify if:

  • Age \<18 years Lymphedema Edema of cardiac or nephrogenic origin Diabetes mellitus Thyroid dysfunction Oncological diseases Polyneuropathy or radiculopathy Advanced degenerative diseases affecting the extremities Use of antiepileptic or antidepressant drugs within the last 6 months Use of edema-inducing medications (e.g., corticosteroids, calcium channel blockers, gabapentin, pregabalin) Cognitive impairment preventing participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Education and Training Hospital

Istanbul, Ataşehir, 34752, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lipedema

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Feyza Akan Begoğlu

    Fatih Sultan Mehmet Education and Training Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2026

First Posted

April 17, 2026

Study Start

January 1, 2026

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations